Hemagglutination Inhibition Tests
"Hemagglutination Inhibition Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.
| Descriptor ID |
D006385
|
| MeSH Number(s) |
E01.370.225.812.735.370 E05.200.812.735.370 E05.478.594.760.370
|
| Concept/Terms |
Hemagglutination Inhibition Tests- Hemagglutination Inhibition Tests
- Hemagglutination Inhibition Test
- Inhibition Test, Hemagglutination
- Inhibition Tests, Hemagglutination
- Test, Hemagglutination Inhibition
- Tests, Hemagglutination Inhibition
|
Below are MeSH descriptors whose meaning is more general than "Hemagglutination Inhibition Tests".
Below are MeSH descriptors whose meaning is more specific than "Hemagglutination Inhibition Tests".
This graph shows the total number of publications written about "Hemagglutination Inhibition Tests" by people in this website by year, and whether "Hemagglutination Inhibition Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 2 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 26 | 28 |
| 2018 | 1 | 21 | 22 |
| 2019 | 1 | 17 | 18 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hemagglutination Inhibition Tests" by people in Profiles.
-
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season. Clin Infect Dis. 2020 09 12; 71(6):1447-1453.
-
Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination. Viruses. 2019 09 30; 11(10).
-
Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults =65 years of age: A phase 3 randomized clinical trial. Vaccine. 2019 09 16; 37(39):5825-5834.
-
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children. Clin Infect Dis. 2019 08 16; 69(5):786-794.
-
Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development. Vaccine. 2019 11 08; 37(47):6933-6941.
-
Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults. Vaccine. 2019 08 23; 37(36):5171-5176.
-
Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection. J Infect Dis. 2019 07 31; 220(5):743-751.
-
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents. Vaccine. 2019 08 23; 37(36):5161-5170.
-
Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice. Vaccine. 2019 07 26; 37(32):4533-4542.
-
An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines. Vaccine. 2019 07 18; 37(31):4246-4255.